Lakefront Biotherapeutics | GLPG - Modal Saham Biasa

Keuangan

EUR

EUR 3.35B

EUR 135.95M

Biaya Penjualan

EUR 9.15M

EUR 2.31B

Kewajiban Lancar

EUR 70.32M

EUR 6.44M

Dividen - Hasil

0

EUR -43.51M

EUR -63.7M

1.34K

Eps Laba Per Saham

EUR -0.2

Modal Dan Cadangan

EUR 3.26B

Laba Kotor Pada Penjualan

EUR 1.68M

Beban Bunga Utang

EUR 1.72M

Pendapatan Bunga

EUR 13.56M

EUR 4.77M

Kapitalisasi Pasar

EUR 1.59B

Batas Pemasukan

EUR 2.11M

Biaya Operasional

EUR 55.62M

Laba Operasional

EUR -43.51M

Modal Saham Biasa

EUR 65.66M

Pe Harga Untuk Laba

2.68

Laba Sebelum Pajak

EUR 13.96M

Pendapatan Penjualan

EUR 12.11M

Beban Penjualan Dan Administrasi

EUR 22.51M

EUR 17.69M

Kreditur Perdagangan

EUR 66.35M

Debitur Perdagangan

EUR 149.47M

	Modal Saham Biasa	Perubahan		Tanggal
argenx SE	USD 62.54M		2.74M	2026-06
AstraZeneca	USD 1.55B		44K	2026-06
Biogen	USD 146.7M		200K	2025-09
Genmab	DKK 61.44M		181K	2026-06
Gilead Sciences	USD 1.24B		1000K	2026-06
GlaxoSmithKline	GBP 4.08B		20.6M	2026-06
GRIFOLS	EUR 680.58M		6K	2026-06
Hikma Pharmaceutical	USD 221.89M		181.89M	2025-12
Incyte	USD 200.98M		1.03M	2026-06
Merck	EUR 434.78M		0	2026-06
Neurocrine Biosciences	USD 100.55M		50K	2026-06
Novartis	USD 1.9B		7.38M	2026-06
Roche Holding	CHF 796.77M		1.15M	2026-06
Sanofi	EUR 1.21B		8.25M	2026-03
UCB	EUR 190.36M		365.15K	2025-12
Vertex Pharmaceuticals	USD 253.3M		900K	2026-06